10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
The current price of TXG is $24.62 USD — it has increased by +3.97% in the past 24 hours. Watch 10x Genomics stock price performance more closely on the chart.
What is 10x Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange 10x Genomics stocks are traded under the ticker TXG.
Is 10x Genomics stock price growing?▼
TXG stock has risen by +10.45% compared to the previous week, the month change is a +11.5% rise, over the last year 10x Genomics has showed a +201.35% increase.
What is 10x Genomics market cap?▼
Today 10x Genomics has the market capitalization of 2.9B
When is the next 10x Genomics earnings date?▼
10x Genomics is going to release the next earnings report on August 06, 2026.
What were 10x Genomics earnings last quarter?▼
TXG earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.28 USD resulting in a +63.65% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 10x Genomics revenue for the last year?▼
10x Genomics revenue for the last year amounts to 1.29B USD.
What is 10x Genomics net income for the last year?▼
TXG net income for the last year is -87.09M USD.
How many employees does 10x Genomics have?▼
As of May 26, 2026, the company has 1,306 employees.
In which sector is 10x Genomics located?▼
10x Genomics operates in the Health & Wellness sector.
When did 10x Genomics complete a stock split?▼
10x Genomics has not had any recent stock splits.
Where is 10x Genomics headquartered?▼
10x Genomics is headquartered in Pleasanton, United States.